Experience our brand-new learning platform with a faster dashboard,
better performance, live classes, current affairs, test series,
and many more exciting features.
The WHO has approved a new, simpler version of an existing oral cholera vaccine, which should help increase the number of available doses as global cases surge.
The Euvichol-S vaccine is a simplified formulation of Euvichol-Plus, with fewer components.
It is produced by EuBiologicals Co., Ltd, South Korea.
The liquid vaccine has a 24-month shelf life.
ABOUT CHOLERA:
Cholera is an acute diarrhoeal infection caused by eating or drinking food or water that is contaminated with the bacterium Vibrio cholerae.
Cholera remains a global threat to public health and is an indicator of inequity and lack of social development.
Researchers have estimated that every year, there are 1.3 to 4 million cases of cholera, and 21,000 to 143,000 deaths worldwide due to the infection.
Cholera is an extremely serious disease that can cause severe acute watery diarrhoea with severe dehydration.
It takes between 12 hours and five days for a person to show symptoms after consuming contaminated food or water.
Cholera affects both children and adults and can kill within hours if untreated.
Currently, 23 countries are reporting cholera outbreaks. The most severe impacts are being felt in the Comoros, the Democratic Republic of Congo, Ethiopia, Mozambique, Somalia, Zambia and Zimbabwe.